About
Dayton Misfeldt is a Partner at Decheng Capital, which he joined in January 2021. He was previously a Managing Director at Bay City Capital, where he invested in biopharmaceutical companies and supported management teams on strategy, business development, and exits, and earlier worked as a sell-side analyst at Roth Capital Partners and in consulting at LifeScience Economics. He holds a BA in Economics from the University of California, San Diego.
Contact· self-published, not guessed
Invests in
Biotech
Experience
- Decheng CapitalPartnercurrent2021 — presentMenlo Park, California, United States
- Bay City CapitalPartner2000 — 2020
Skills & more
Venture Capital7Lifesciences5Pharmaceutical Industry6
From Dayton's professional profile.
Investments
Board seats
ExcellergyUpstream Bio
Investor
Cadence PharmaceuticalsCivitas TherapeuticsDermiraExcellergyMAP PharmaceuticalsNextwave PharmaceuticalsOculex PharmaceuticalsPharmion
Per the firm's website.
Colleagues at Decheng Capital
Aaron Li
Principal at Decheng Capital
Claire Zhang
Senior Associate at Decheng Capital
Joan Chen
Vice President at Decheng Capital
Katherine Xu
Partner at Decheng Capital
Michael Notaras
Vice President at Decheng Capital
Min Cui
Founder and Managing Director at Decheng Capital
Nick Pliam
Venture Partner at Decheng Capital
Peter Colabuono
Managing Director at Decheng Capital
Frequently asked questions
- Who is Dayton Misfeldt?
- Dayton Misfeldt is a Partner at Decheng Capital, which he joined in January 2021. He was previously a Managing Director at Bay City Capital, where he invested in biopharmaceutical companies and supported management teams on strategy, business development, and exits, and earlier worked as a sell-side analyst at Roth Capital Partners and in consulting at LifeScience Economics. He holds a BA in Economics from the University of California, San Diego.
- Where does Dayton Misfeldt work?
- Dayton Misfeldt is Partner at Decheng Capital.
- What does Dayton Misfeldt invest in?
- Dayton Misfeldt invests in Biotech.
- What boards does Dayton Misfeldt sit on?
- Dayton Misfeldt holds tracked board seats at Excellergy, Upstream Bio.
- What companies has Dayton Misfeldt invested in?
- Investments tracked here include Cadence Pharmaceuticals, Civitas Therapeutics, Dermira, Excellergy, MAP Pharmaceuticals, Nextwave Pharmaceuticals, Oculex Pharmaceuticals, Pharmion.
- Where did Dayton Misfeldt go to school?
- Dayton Misfeldt studied at UC San Diego.
Same school
Also attended UC San Diego307
Elad GilSolo general partner investing through Gil CapitalMark SusterManaging Partner at Upfront VenturesChester NgGeneral Partner at AtomicBirgitteInvestor at InvestinorHouman HaghighiPartner, Business & Corporate Development at Menlo VenturesFreya Svedberg-KeatingInvestor at Medicxi
+ 301 more
Shared employers
Also worked at Bay City Capital8
Victor Tong, Jr.Managing Director at Decheng CapitalAndy SchwabManaging Partner at 5AM VenturesFred CravesManaging Director at Bay City CapitalKirby BartlettCOO and CFO at Construct CapitalMike MastersonCo-Founder and Managing Partner at Supermoon CapitalRob HopfnerManaging Director at Pivotal Life Sciences
.avif)
+ 2 more